Research programme: antifungal drug hyaluronan complex - Meditech Research
Alternative Names: Antifungal drug hyaluronan complex research programme - Meditech ResearchLatest Information Update: 07 May 2010
At a glance
- Originator Meditech Research
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 07 May 2010 Discontinued - Preclinical for Mycoses in Australia (unspecified route)
- 31 Dec 2001 Preclinical trials in Mycoses in Australia (unspecified route)